GLSI Stock Analysis: Buy, Sell, or Hold?
GLSI - Greenwich LifeSciences, Inc.
$22.00
-1.70 (-7.17%)
▼
5d:
+20.02%
30d:
-9.43%
90d:
-4.18%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When GLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: GLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: GLSI is currently trading at $22.00, which is considered slightly low relative to its 30-day fair value range of $21.27 to $26.24.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $20.91, while resistance sits at $29.93. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: GLSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.50 (+115.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $20.91, while resistance sits at $29.93. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: GLSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.50 (+115.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$21.27 -
$26.24
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 115.9% below Wall St target ($47.50)
Trading Range Analysis
30-Day Trading Range
$21.27 -
$26.24
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.91
Resistance Level
$29.93
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$47.50
(+115.9%)
Share & Embed Analysis
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLSI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Snehal Patel
BUY
1800 shares
2026-01-13
Snehal Patel
BUY
2900 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
